Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19

In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and u...

Full description

Saved in:
Bibliographic Details
Published in:Cell Stem Cell 2020-06, Vol.26 (6), p.806-810
Main Author: Turner, Leigh
Format: Article
Language:English
Subjects:
Betacoronavirus
Commerce
Coronavirus Infections - prevention & control
Coronavirus Infections - psychology
Coronavirus Infections - therapy
COVID-19
Fear
Forum
Humans
Marketing
Pandemics - prevention & control
Pneumonia, Viral - prevention & control
Pneumonia, Viral - psychology
Pneumonia, Viral - therapy
SARS-CoV-2
Stem Cell Transplantation - economics
Stem Cell Transplantation - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2020.05.003